This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
KUALA LUMPUR (Aug 21): Shares of Petronas Chemicals Group Bhd, Petronas Gas Bhd and Petronas Dagangan Bhd rose among Bursa Malaysia's top gainers today after these companies reported higher second quarter net profit from a year earlier and declared dividends.
PNADF 5183 PECGF 5681 BSMAF PNAGF 6033 1818
Petronas Gas Bhd (Aug 16, RM18.38) Maintain sell with a higher fair value (FV) of RM17.50: We maintain our “sell” recommendation for Petronas Gas Bhd (PetGas) but with a higher sum-of-parts-based FV of RM17.50 per share (from an earlier RM16.80 per share), which implies a financial year ended 2018 forward (FY18F) price-earnings ratio (PER) of 18 times, a 20% discount to the two-year average of 23 times.
PNADF 5347 TNABY TNABF PNAGF 6033
KUALA LUMPUR, Aug 16 — Bursa Malaysia ended lower today on continued selling in index-linked counters as sentiment remains bearish, amid global trade tensions and geopolitical uncertainty, dealers said.
PNADF PBLOF 0026 1295 BSMAF PNAGF 6033 1818
KUALA LUMPUR: Petronas Gas Bhd’s (PetGas) net profit rose 19.7% to RM509.33 million in the second quarter ended June 30, 2018 (2QFY18) from RM425.33 million a year ago, on the back of higher revenue and lower tax expenses negated by higher finance cost. Earnings per share rose to 25.74 sen from 21.49 sen.
PNADF PNAGF 6033
KUALA LUMPUR, Aug 16 — Bursa Malaysia opened lower today weighed down by selling activities in most heavyweights, taking the cue from the weaker performance on Wall Street and European stock markets overnight, dealers said.
TGLVY PNADF PBLOF 5819 7113 TPGVF 1295 BSMAF PNAGF 6033 1818
KUALA LUMPUR (Aug 15): Based on corporate announcements and news flow today, stocks in focus tomorrow may include: Public Bank Bhd, Press Metal Aluminium Holdings Bhd, KLCCP Stapled Group, CIMB Group Holdings Bhd, Petronas Chemicals Group Bhd, Petronas Gas Bhd, Sam Engineering & Equipment (M) Bhd, Oriental Interest Bhd, Scientex Bhd, Mudajaya Group Bhd and MK Land Holdings Bhd.
PBLOF 5183 PECGF 5085 1295 6033 8893 CIMDF 1023 PNADF 8869 5827 PNAGF
KUALA LUMPUR, Aug 15 — Bursa Malaysia closed higher today on continued mild buying in selected heavyweights led by Public Bank, as well as mid and small-cap stocks, amid the weaker trend in most regional peers, dealers said.
PNADF PBLOF 7036 5681 1295 BSMAF PNAGF 6033 1818
KUALA LUMPUR (Aug 15): Petronas Gas Bhd's (PetGas) net profit for the second quarter ended June 30, 2018 rose 20% to RM509.33 million from RM425.33 million a year earlier, on the back of higher revenue and lower tax expenses negated by higher finance cost.
PNADF BSMAF PNAGF 6033 1818
KUALA LUMPUR (Aug 15): The FBM KLCI held on to its marginal gains at mid-morning today, despite the retreat at most regional markets, propped up by Petronas-linked stocks.
APEXF 5161 7090 0090 7192 8621 5681 JCYBF BATS 4162 7034 6033 5101 PNADF 3301 5797 6556 5819 PNAGF
23h - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
23h - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET